Sign in

mcalderwood.bsky.social

@mcalderwood.bsky.social
49 followers 116 following 0 posts
PostsRepliesMedia
Reposted by @mcalderwood.bsky.social
Computational & Systems Biology Dept. at Pitt @csbpitt.bsky.social · 06/08/2026
New research from Warren van Loggerenberg and Fritz Roth sheds light on the variants that cause APS-1, a rare immunodeficiency disease. They assessed the function of 9,790 of these pathogenic variants in their variant effect map. Read the full research article: tinyurl.com/RothVariants
tinyurl.com
Systematic and proactive evaluation of AIRE missense variant effects
Pathogenic variants in the autoimmune regulator (AIRE) cause autoimmune polyendocrine syndrome type 1 (APS-1), a rare primary immunodeficiency disease…
001
Reposted by @mcalderwood.bsky.social
Katja Luck @katjaluck.bsky.social · 31/07/2026
Check out our new article if you are interested in disorder-mediated protein interactions, AlphaFold-based structural modeling and variant characterization: rdcu.be/fw2oz Dx.doi.org/10.1038/s41594-026-01846-z
dx.doi.org
Variant characterization in the intrinsically disordered human proteome - Nature Structural & Molecular Biology
Proteome-wide prediction and structural modeling of disordered protein interaction interfaces advance characterization of disease-associated variants in disordered protein regions.
23715
Reposted by @mcalderwood.bsky.social
Jeff Calhoun @calhoujd.bsky.social · 11/07/2026
Our paper on integrating data from 2+ multiplexed assays of variant effect (MAVE) for the same gene is available now: doi.org/10.1186/s130... We also have a Shiny webtool where you can plug in data and compare a few different integration approaches. A big thank you to all co-authors... 1/3
doi.org
Combining multiplexed functional data to improve variant classification - Genome Medicine
Background With the surge in the number of variants of uncertain significance (VUS) reported in ClinVar in recent years, there is an imperative to resolve VUS at scale. Multiplexed assays of variant effect (MAVEs), which allow the functional consequence of 100s to 1000s of genetic variants to be measured in a single experiment, are emerging as a powerful source of evidence which can be used in clinical variant classification. Increasingly, multiple published MAVEs are available for the same gene, sometimes measuring different aspects of variant impact. When multiple functional roles of a gene need to be considered, combining data from multiple MAVEs may provide a more comprehensive measure of the consequence of a genetic variant, which could impact variant classifications. Methods We curated published datasets from five MAVEs for the gene TP53, two MAVEs for LDLR and two MAVEs for PTEN. Statistical methods (principal component analysis), unsupervised learning (k-means clustering), and supervised learning (Naïve Bayes and random forest classifiers) were used to integrate multiple MAVE datasets. The utility of MAVE integration methods were assessed using standard metrics (sensitivity, specificity, etc) as well as evidence strength in a putative variant classification framework. Results Here, we provide guidance for combining such multiplexed functional data, incorporating a stepwise process from data curation and collection to model generation and validation. We also present a web applet that allows users to test various methods for combining score sets from multiple assays, calculate integrated functional scores for all variants, and assess whether combining data enables the application of stronger evidence for pathogenicity or benignity. In general, supervised learning methods such as random forest led to improved variant classification as compared to any individual MAVE dataset. Conclusions By following the steps outlined herein with appropriate guardrails, researchers can maximize the value of MAVEs, strengthen the functional evidence for clinical variant classification, and potentially uncover novel mechanisms of pathogenicity for clinically relevant genes.
134
Reposted by @mcalderwood.bsky.social
Luke Lambourne @lukelambourne.bsky.social · 03/06/2026
Excited that the final version of our experimental assessment of AI protein interaction predictions is out: www.nature.com/articles/s41... Brief summary below:
nature.com
Experimental assessment of AI-based interactome mapping - Nature Communications
AlphaFold’s success in protein structure predictions has led to similar attempts to predict interactomes. Here, the authors demonstrate that AI-based screens are very limited in discovering truly nove...
144
Reposted by @mcalderwood.bsky.social
Pascal Falter-Braun @interactome.bsky.social · 20/04/2026
new publication in #Nature Commun evaluating PPI prediction by #AlphaFold & co for yeast and human compared to exp. screening. We show AF predictions at stringent cut-off are high quality. But true novelty is sparse and the experiment outperforms pred. nearly 40-fold. www.nature.com/articles/s41...
nature.com
Experimental assessment of AI-based interactome mapping - Nature Communications
AlphaFold’s success in protein structure predictions has led to similar attempts to predict interactomes. Here, the authors demonstrate that AI-based screens are very limited in discovering truly nove...
273
Reposted by @mcalderwood.bsky.social
Alexis Verger 🧬🧫🧪 @alexis-verger.cpesr.fr · 07/04/2026
🍿 "Our results suggest that, at this stage, the main contribution of AI predictions is to provide quaternary structure models for experimentally identified PPIs." #alphafold www.nature.com/articles/s41...
nature.com
Experimental assessment of AI-based interactome mapping - Nature Communications
AlphaFold’s success in protein structure predictions has led to similar attempts to predict interactomes. Here, the authors demonstrate that AI-based screens are very limited in discovering truly nove...
0135
Reposted by @mcalderwood.bsky.social
bioRxiv Genomics @biorxiv-genomic.bsky.social · 15/02/2026
A scalable approach to resolving variants of uncertain significance www.biorxiv.org/content/10.64898/20…
053
Reposted by @mcalderwood.bsky.social
Nature Microbiology @natmicrobiol.nature.com · 26/01/2026
Out Now! Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation #MicroSky
go.nature.com
Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation
Nature Microbiology, Published online: 26 January 2026; doi:10.1038/s41564-025-02241-yLarge-scale computational and in vitro analyses identify commensal type III secretion systems and substrates in the human gut microbiome that can interact with human proteins to modulate immune pathways.
0157
Reposted by @mcalderwood.bsky.social
Pascal Falter-Braun @interactome.bsky.social · 26/01/2026
Very happy and proud that our paper “Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation” is out today in #NatureMicrobiology @natmicrobiol.nature.com Paper 👉 t1p.de/v42xb #microbiome #commensal #pathomechanism #T3SS #immune #health #IBD
t1p.de
Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation - Nature Microbiology
Large-scale computational and in vitro analyses identify commensal type III secretion systems and substrates in the human gut microbiome that can interact with human proteins to modulate immune pathwa...
12511
Reposted by @mcalderwood.bsky.social
Irene Gallego Romero @ee-reh-neh.bsky.social · 02/10/2025
I'm stoked to be organising next year's MSS right here in beautiful Melbourne! We know Australia is very far away, and we're working hard to make sure we can support as many ECRs to attend as possible, so please do register and apply for a travel award!
1108
Reposted by @mcalderwood.bsky.social
Lara Muffley @muffley.bsky.social · 10/09/2025
brotmanbaty.org/news/new-vis...
011
Reposted by @mcalderwood.bsky.social
Jess Ewald @ewaldlab.org · 07/08/2025
Check out this opportunity to join my lab as a postdoc! www.ebi.ac.uk/research/pos... Every year, faculty from EMBL-EBI and the Wellcome Sanger Institute co-develop projects that allow fellows to be part of ✨both✨ of these amazing research institutes.
ebi.ac.uk
EMBL-EBI-Sanger postdoctoral fellowships (ESPOD)
The ESPOD fellowship builds on the collaborative relationship between EMBL-EBI and the Wellcome Sanger Institute, offering projects that combine experimental (wet-lab) and computational (dry-lab) appr...
31114
Reposted by @mcalderwood.bsky.social
Katja Luck @katjaluck.bsky.social · 01/07/2025
Variant characterization in the intrinsically disordered human proteome - here is how we did it using short linear motif prediction, AlphaFold, and experimentation. Check out our preprint: www.biorxiv.org/cgi/content/...
biorxiv.org
Variant characterization in the intrinsically disordered human proteome
Variant effect prediction remains a key challenge to resolve in precision medicine. Sophisticated computational models that exploit sequence conservation and structure are increasingly successful in t...
02211
Reposted by @mcalderwood.bsky.social
Molecular Cell @cp-molcell.bsky.social · 08/04/2025
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms
dlvr.it
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms
Lambourne, Mattioli, Santoso, et al. compare protein isoforms of the same transcription factor genes through high-throughput profiling of DNA-binding, protein-binding, activation, localization, and condensate formation. Differences between isoforms are widespread, often unpredictable from sequence differences, and inform a disease-associated categorization of alternative isoforms into rewirers or negative regulators.
042
Reposted by @mcalderwood.bsky.social
Molecular Cell @cp-molcell.bsky.social · 27/03/2025
Online Now: Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms Online now:
dlvr.it
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms
Lambourne, Mattioli, Santoso, et al. compare protein isoforms of the same transcription factor genes through high-throughput profiling of DNA-binding, protein-binding, activation, localization, and condensate formation. Differences between isoforms are widespread, often unpredictable from sequence differences, and inform a disease-associated categorization of alternative isoforms into rewirers or negative regulators.
042
Reposted by @mcalderwood.bsky.social
Jess Ewald @ewaldlab.org · 05/03/2025
🚨 We're hiring! 🚨 The Ewald Lab at EMBL-EBI is looking for a postdoctoral researcher in multi-omics, machine learning, and predictive toxicology to analyze a groundbreaking toxicology dataset as part of the OASIS Consortium. More details & application here: lnkd.in/eHD7DMdX
211556